Document is current
Any future updates will be listed below
-
Authors
Martins, Paulo
Vandewalle, Björn
Félix, Jorge
Capela, Carlos M.
Cerqueira, João J.
Salgado, António V.
Ferreira, Diana G.
Monteiro, Isabel
-
Funding
Funding for this research was provided by:
Roche Farmacêutica e Química Lda, Portugal
- License Information
-
More Information
Article History
Accepted: 9 November 2022
First Online: 1 December 2022
Declarations
:
: This study was supported by Roche Farmacêutica e Química, Lda., Portugal.
: PM, BV and JF are employed by Exigo Consultores. The study sponsor contracted with Exigo Consultores for the development of the research project. Exigo Consultores provided support in the form of salaries for authors but did not have any additional role in the study design, data collection and analysis, or preparation of the manuscript. CC has received compensation for advisory board/consulting services to Biogen, Janssen, Merck, Novartis, Roche, and Sanofi, and has been on the speakers’ bureau for Almirall, Biogen, BMS, Janssen, Merck, Novartis, Roche, and Sanofi. JC has received compensation for activity with Almirall, Biogen, Bristol-Myers-Squibb, Janssen, Merck, Novartis, Roche, Sanofi, and Zambon. AS has received compensation for activity with Astra Zeneca, Biogen, Merck, Novartis, Roche, and Sanofi. DF and IM are employees of Roche Farmacêutica e Química, Lda., Portugal.
: Not applicable.
: Not applicable.
: Not applicable.
: All data and material relevant to the analysis are presented in the outlined publication or supplementary material. The model used in this study was provided to the journal’s peer reviewers for their reference when reviewing the manuscript.
: The authors will answer any enquiries regarding the details of the analysis should these have not been answered by the information provided in the methods section.
: PM: study design, data collection, analytical calculations, interpretation of results, drafting and critical revision of the manuscript; BV: study design, interpretation of results and critical revision of the manuscript; JF: interpretation of results, drafting and critical revision of the manuscript; CMC: interpretation of results and critical revision of the manuscript; JJC: interpretation of results and critical revision of the manuscript; AVS: interpretation of results and critical revision of the manuscript; DGF: study conception, study design, interpretation of results, critical revision of the manuscript; IM: study conception, study design, interpretation of results, critical revision of the manuscript.
